A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

October 16, 2024

Study Completion Date

October 16, 2024

Conditions

Healthy

Interventions

DRUG

zongertinib

zongertinib, Hernexeos®

DRUG

midazolam

DRUG

omeprazole

DRUG

repaglinide

Trial Locations (1)

Humanpharmakologisches Zentrum Biberach, Biberach